AAPL303.42-5.49 (-1.78%) ▼|ABBV245.10-5.84 (-2.33%) ▼|ABT107.12+1.42 (+1.34%) ▲|ACN165.76-0.16 (-0.10%) ▼|ADBE251.34+0.93 (+0.37%) ▲|AMAT518.21+10.54 (+2.08%) ▲|AMD484.64+8.49 (+1.78%) ▲|AMGN378.87-6.29 (-1.63%) ▼|AMT173.00-0.36 (-0.21%) ▼|AMZN284.02+12.44 (+4.58%) ▲|AVGO392.23+2.95 (+0.76%) ▲|AXP344.72+8.47 (+2.52%) ▲|BA233.49+17.35 (+8.03%) ▲|BAC62.48+0.53 (+0.86%) ▲|BKNG192.71-0.19 (-0.10%) ▼|BLK1,126.63+36.24 (+3.32%) ▲|BMY65.47+0.16 (+0.25%) ▲|BNY156.20-0.13 (-0.08%) ▼|BRK-B513.14+1.60 (+0.31%) ▲|C133.57+1.79 (+1.36%) ▲|CAT830.03+15.22 (+1.87%) ▲|CL89.88-1.42 (-1.56%) ▼|CMCSA24.56+0.60 (+2.50%) ▲|COF217.68+8.67 (+4.15%) ▲|COP119.16-1.32 (-1.10%) ▼|COST954.08+2.19 (+0.23%) ▲|CRM185.95+1.93 (+1.05%) ▲|CSCO115.86-0.13 (-0.11%) ▼|CVS105.37+0.94 (+0.90%) ▲|CVX193.18-3.65 (-1.85%) ▼|DE605.06+12.39 (+2.09%) ▲|DHR197.50+2.52 (+1.29%) ▲|DIS98.14+1.95 (+2.03%) ▲|DUK124.28-1.15 (-0.92%) ▼|EMR154.85+5.03 (+3.36%) ▲|FDX309.24+1.84 (+0.60%) ▲|GD382.43-0.99 (-0.26%) ▼|GE368.93+8.86 (+2.46%) ▲|GEV1,006.76+16.47 (+1.66%) ▲|GILD131.15+0.94 (+0.72%) ▲|GM87.68-1.18 (-1.33%) ▼|GOOG372.47+15.82 (+4.44%) ▲|GOOGL373.51+17.38 (+4.88%) ▲|GS1,027.06+8.68 (+0.85%) ▲|HD340.02+8.06 (+2.43%) ▲|HON246.77+3.72 (+1.53%) ▲|IBM226.31+2.66 (+1.19%) ▲|INTC91.00+0.80 (+0.89%) ▲|INTU318.39+2.32 (+0.73%) ▲|ISRG375.41+22.08 (+6.25%) ▲|JNJ254.41-1.94 (-0.76%) ▼|JPM352.64+0.85 (+0.24%) ▲|KO86.86-0.73 (-0.83%) ▼|LIN480.46+2.08 (+0.43%) ▲|LLY1,121.36-27.48 (-2.39%) ▼|LMT586.29+3.55 (+0.61%) ▲|LOW212.06+4.25 (+2.05%) ▲|LRCX294.61+1.59 (+0.54%) ▲|MA570.97-2.13 (-0.37%) ▼|MCD265.23-5.41 (-2.00%) ▼|MDLZ61.73-0.58 (-0.93%) ▼|MDT86.68+1.29 (+1.51%) ▲|META590.24+33.53 (+6.02%) ▲|MMM177.23+0.95 (+0.54%) ▲|MO68.26-0.07 (-0.10%) ▼|MRK127.77-2.43 (-1.87%) ▼|MS211.23+0.81 (+0.38%) ▲|MSFT487.65+22.93 (+4.93%) ▲|MU829.50+6.47 (+0.79%) ▲|NEE86.55-0.37 (-0.43%) ▼|NFLX73.33+1.62 (+2.26%) ▲|NKE42.64+0.93 (+2.23%) ▲|NOW114.19+2.96 (+2.66%) ▲|NVDA206.64+5.89 (+2.93%) ▲|ORCL141.85+11.98 (+9.22%) ▲|PEP139.63+0.07 (+0.05%) ▲|PFE25.03+0.02 (+0.08%) ▲|PG144.97+0.48 (+0.33%) ▲|PLTR125.65+2.59 (+2.10%) ▲|PM187.41-3.41 (-1.79%) ▼|QCOM151.57+3.96 (+2.68%) ▲|RTX216.65+1.43 (+0.66%) ▲|SBUX103.37-1.88 (-1.79%) ▼|SCHW105.87+0.63 (+0.60%) ▲|SO92.94-1.60 (-1.69%) ▼|SPG229.16-0.21 (-0.09%) ▼|T23.59+0.34 (+1.46%) ▲|TMO574.03-0.27 (-0.05%) ▼|TMUS177.09+4.38 (+2.54%) ▲|TSLA322.08+10.87 (+3.49%) ▲|TXN269.04-6.70 (-2.43%) ▼|UBER71.61+1.25 (+1.78%) ▲|UNH415.36+0.96 (+0.23%) ▲|UNP291.23-0.90 (-0.31%) ▼|UPS106.87+2.65 (+2.54%) ▲|USB63.94+0.93 (+1.48%) ▲|V365.67-0.46 (-0.13%) ▼|VZ47.36+0.55 (+1.18%) ▲|WFC87.89+1.44 (+1.67%) ▲|WMT110.71-0.49 (-0.44%) ▼|XOM155.06-0.38 (-0.24%) ▼|AAPL303.42-5.49 (-1.78%) ▼|ABBV245.10-5.84 (-2.33%) ▼|ABT107.12+1.42 (+1.34%) ▲|ACN165.76-0.16 (-0.10%) ▼|ADBE251.34+0.93 (+0.37%) ▲|AMAT518.21+10.54 (+2.08%) ▲|AMD484.64+8.49 (+1.78%) ▲|AMGN378.87-6.29 (-1.63%) ▼|AMT173.00-0.36 (-0.21%) ▼|AMZN284.02+12.44 (+4.58%) ▲|AVGO392.23+2.95 (+0.76%) ▲|AXP344.72+8.47 (+2.52%) ▲|BA233.49+17.35 (+8.03%) ▲|BAC62.48+0.53 (+0.86%) ▲|BKNG192.71-0.19 (-0.10%) ▼|BLK1,126.63+36.24 (+3.32%) ▲|BMY65.47+0.16 (+0.25%) ▲|BNY156.20-0.13 (-0.08%) ▼|BRK-B513.14+1.60 (+0.31%) ▲|C133.57+1.79 (+1.36%) ▲|CAT830.03+15.22 (+1.87%) ▲|CL89.88-1.42 (-1.56%) ▼|CMCSA24.56+0.60 (+2.50%) ▲|COF217.68+8.67 (+4.15%) ▲|COP119.16-1.32 (-1.10%) ▼|COST954.08+2.19 (+0.23%) ▲|CRM185.95+1.93 (+1.05%) ▲|CSCO115.86-0.13 (-0.11%) ▼|CVS105.37+0.94 (+0.90%) ▲|CVX193.18-3.65 (-1.85%) ▼|DE605.06+12.39 (+2.09%) ▲|DHR197.50+2.52 (+1.29%) ▲|DIS98.14+1.95 (+2.03%) ▲|DUK124.28-1.15 (-0.92%) ▼|EMR154.85+5.03 (+3.36%) ▲|FDX309.24+1.84 (+0.60%) ▲|GD382.43-0.99 (-0.26%) ▼|GE368.93+8.86 (+2.46%) ▲|GEV1,006.76+16.47 (+1.66%) ▲|GILD131.15+0.94 (+0.72%) ▲|GM87.68-1.18 (-1.33%) ▼|GOOG372.47+15.82 (+4.44%) ▲|GOOGL373.51+17.38 (+4.88%) ▲|GS1,027.06+8.68 (+0.85%) ▲|HD340.02+8.06 (+2.43%) ▲|HON246.77+3.72 (+1.53%) ▲|IBM226.31+2.66 (+1.19%) ▲|INTC91.00+0.80 (+0.89%) ▲|INTU318.39+2.32 (+0.73%) ▲|ISRG375.41+22.08 (+6.25%) ▲|JNJ254.41-1.94 (-0.76%) ▼|JPM352.64+0.85 (+0.24%) ▲|KO86.86-0.73 (-0.83%) ▼|LIN480.46+2.08 (+0.43%) ▲|LLY1,121.36-27.48 (-2.39%) ▼|LMT586.29+3.55 (+0.61%) ▲|LOW212.06+4.25 (+2.05%) ▲|LRCX294.61+1.59 (+0.54%) ▲|MA570.97-2.13 (-0.37%) ▼|MCD265.23-5.41 (-2.00%) ▼|MDLZ61.73-0.58 (-0.93%) ▼|MDT86.68+1.29 (+1.51%) ▲|META590.24+33.53 (+6.02%) ▲|MMM177.23+0.95 (+0.54%) ▲|MO68.26-0.07 (-0.10%) ▼|MRK127.77-2.43 (-1.87%) ▼|MS211.23+0.81 (+0.38%) ▲|MSFT487.65+22.93 (+4.93%) ▲|MU829.50+6.47 (+0.79%) ▲|NEE86.55-0.37 (-0.43%) ▼|NFLX73.33+1.62 (+2.26%) ▲|NKE42.64+0.93 (+2.23%) ▲|NOW114.19+2.96 (+2.66%) ▲|NVDA206.64+5.89 (+2.93%) ▲|ORCL141.85+11.98 (+9.22%) ▲|PEP139.63+0.07 (+0.05%) ▲|PFE25.03+0.02 (+0.08%) ▲|PG144.97+0.48 (+0.33%) ▲|PLTR125.65+2.59 (+2.10%) ▲|PM187.41-3.41 (-1.79%) ▼|QCOM151.57+3.96 (+2.68%) ▲|RTX216.65+1.43 (+0.66%) ▲|SBUX103.37-1.88 (-1.79%) ▼|SCHW105.87+0.63 (+0.60%) ▲|SO92.94-1.60 (-1.69%) ▼|SPG229.16-0.21 (-0.09%) ▼|T23.59+0.34 (+1.46%) ▲|TMO574.03-0.27 (-0.05%) ▼|TMUS177.09+4.38 (+2.54%) ▲|TSLA322.08+10.87 (+3.49%) ▲|TXN269.04-6.70 (-2.43%) ▼|UBER71.61+1.25 (+1.78%) ▲|UNH415.36+0.96 (+0.23%) ▲|UNP291.23-0.90 (-0.31%) ▼|UPS106.87+2.65 (+2.54%) ▲|USB63.94+0.93 (+1.48%) ▲|V365.67-0.46 (-0.13%) ▼|VZ47.36+0.55 (+1.18%) ▲|WFC87.89+1.44 (+1.67%) ▲|WMT110.71-0.49 (-0.44%) ▼|XOM155.06-0.38 (-0.24%) ▼|
23.7 C
New York
Tuesday, August 4, 2026

Tag: home

newssourceFORcompanyinformationcontent1releasesmarket

VERSACE HOME UNVEILS ITS EIGHT HAUTE COUTURE VILLAS IN MARBELLA

THE SALES OFFICE IS LOCATED IN PUERTO BANÚS The presentation event was attended by Marbella's mayor and prominent figures from the fashion, business, and sports...

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

Deakin University GIFT City Campus, India, announced ‘Winner’ at Economic Times Education Excellence Awards 2025

NEW DELHI, June 20, 2025 /PRNewswire/ -- Deakin University is proud to announce that its GIFT City Campus in Gandhinagar, India, has been awarded...

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Fed Maintains Interest Rates—Evaluate Implications for Credit Cards, Auto Loans, Mortgages

The Federal Reserve's decision to maintain the current interest rate reflects a strategic pause amid an evolving economic landscape. Given President Trump's calls for...

Chinese Firms Eye Brazil—Because Who Needs Stability Anyway?

Amid the relentless cacophony of trade wars and collapsing markets, Chinese consumer brands, with a touch of desperation and a sprinkle of audacity, have...

SAINT-GOBAIN ENHANCES ITS DIGITAL CONSTRUCTION CHEMICALS PLATFORM WITH THE ACQUISITION OF MATURIX

PARIS, June 19, 2025 /PRNewswire/ -- Saint-Gobain announces the next step in the expansion of its digital construction chemicals platform with the acquisition of...

HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support

HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care 
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care

OdorCrush Laundry Balls Website Refresh Highlights Eco-Friendly Household Solution

Updated Website Details How OdorCrush Laundry Balls Promote Reusable, Non-Toxic Laundry Routines for Eco-Conscious Homes 
Updated Website Details How OdorCrush Laundry Balls Promote Reusable, Non-Toxic Laundry Routines for Eco-Conscious Homes

SAINT-GOBAIN ENHANCES ITS DIGITAL CONSTRUCTION CHEMICALS PLATFORM WITH THE ACQUISITION OF MATURIX

PARIS, June 20, 2025 /PRNewswire/ -- Saint-Gobain announces the next step in the expansion of its digital construction chemicals platform with the acquisition of...

/C O R R E C T I O N — 50 Best/

In the news release, MAIDO, LIMA, IS NAMED NO.1 IN THE LIST OF THE WORLD'S 50 BEST RESTAURANTS 2025, issued June 19, 2025 by...

Dystany Spurlock to Make NHRA History With Support From Foxxtecca

DETROIT, June 19, 2025 /PRNewswire/ -- Foxxtecca is making history with professional motorcycle drag racer Dystany Spurlock, who will become only the second Black...

MAIDO, LIMA, IS NAMED NO.1 IN THE LIST OF THE WORLD’S 50 BEST RESTAURANTS 2025

TURIN, Italy, June 19, 2025 /PRNewswire/ -- The world of gastronomy came together in Turin, Region of Pidemont, this evening to celebrate The World's...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHome

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers